Drug Used to Manage Congestive Heart Failure in Dogs Earns FDA Approval

Company Announcement Date: 28/07/2020
Product Type: Congestive Heart Failure Medication for Dogs
Reason for Announcement: Cardalis used to manage congestive heart failure in dogs earns FDA approval
Company Name: Ceva Animal Health Inc.
Brand Name: Cardalis
Author(s): Graeme Carey

The U.S. Food and Drug Administration recently approved of a drug from Ceva Animal Health used for the management of congestive heart failure in dogs brought on by atrioventricular valvular insufficiency (AVVI). Cardalis, which has been prescribed in Europe since 2012, is a chewable tablet that contains spironolactone and benazepril hydrochloride.

Until now, dogs with AVVI had been treated with these same active substances via the off-label use of products approved for humans.

“Today’s approval is novel because the drugs are now approved in a combination found to be safe and effective for canine patients,” reads the July 28 report from the FDA. Cardalis will be made available in three dosages (2.5 mg benazepril hydrochloride/20 mg spironolactone, 5 mg/40 mg, and 10 mg/80 mg) and packaged in bottles of 30.

Any dog can get AVVI, but it is especially common among older, smaller breeds, including Cavalier King Charles Spaniels, Dachshunds, Miniature and Toy Poodles, Chihuahas, and Yorkshire Terriers.

The drug was determined to be safe and effective in a 12-month field study that looked at 569 dogs with the disease:

In the study Cardalis was compared to the active control, benazepril hydrochloride, for the management of clinical signs of congestive heart failure in dogs due to AVVI, and to demonstrate the contribution of spironolactone to the effectiveness of the Cardalis combination drug product.

Another study found that healthy dogs were able to tolerate the drug at up to five times the recommended maximum dosage for a period of six months, further demonstrating its safety.

As the FDA’s report notes, AVVI is the most common form of heart disease among dogs, affecting up to 85% of small breeds by the age of 13. Fortunately, if detected early on and treated by a veterinarian with the proper medication, it can be managed.

Summary
Drug Used to Manage Congestive Heart Failure in Dogs Earns FDA Approval
Article Name
Drug Used to Manage Congestive Heart Failure in Dogs Earns FDA Approval
Description
The U.S. Food and Drug Administration recently approved of a drug from Ceva Animal Health used for the management of congestive heart failure in dogs brought on by atrioventricular valvular insufficiency (AVVI).
Author
Publisher Name
Healthcare for Pets
Publisher Logo

Disclaimer: healthcareforpets.com and its team of veterinarians and clinicians do not endorse any products, services, or recommended advice. All advice presented by our veterinarians, clinicians, tools, resources, etc is not meant to replace a regular physical exam and consultation with your primary veterinarian or other clinicians. We always encourage you to seek medical advice from your regular veterinarian.

Recent News

  • Sunshine Mills, Inc. Expands Recall of Pet Food Products Due to Elevated Levels of Aflatoxin
  • Oct 10, 2020
  • Real Pet Food Company Recalls One Lot of Billy+Margot Wild Kangaroo and Superfoods Recipe Dog Food Due to Possible Salmonella Risk
  • Sep 26, 2020
  • Sunshine Mills, Inc. Issues Recall of Some Dog Food Products Due to Potentially Elevated Levels of Aflatoxin
  • Sep 3, 2020
  • Sunshine Mills, Inc. Issues Recall of Nature’s Menu® Super Premium Dog Food with a Blend of Real Chicken & Quail Due to Possible Salmonella Health Risk
  • Aug 24, 2020
  • InHe Manufacturing, LLC and MHR Brands Recalls Several Products Due to Potential Risk of Excess Lead
  • Jul 23, 2020
Question & AnswerQ&A
DON’T MISS OUT!
Subscribe To Our Newsletter
Be the first to get the latest pet health news and exclusive content straight to your inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link